BRUCEGOURLEY.COM 

 PLACENTAL TISSUE AND CELLS
 While the debate over stem cells rage, a new development signals a way past the impasse.

HOME

 

 

 

 

 

 

 

 

   

 Placental tissue and cells hold remarkable promise in the world of medicine.

 


A BRIEF INTRODUCTION TO PLACENTAL TISSUE AND CELL RESEARCH

What is at Stake?
Embryonic stem cell research offers the promise of curing many serious illnesses, including juvenile diabetes, Parkinson's disease and spinal cord injury, because the stem cells can be grown into a variety of organs.

However, critics have long maintained that the use of embryonic stem cells is morally wrong because it often requires the destruction of embryos to produce the stem cells.  In 2001, the Bush administration put the brakes on further federal funding of embryonic stem cell research.  As a result, much of the current embryonic stem cell research is taking place in the private sector, proceeding at a slower pace than if federal monies were available.

Beyond the Impasse
Placental tissue and cells, the material which is typically discarded following birth, offers a potential avenue of moving beyond the impasse over stem cells.

One company on the cutting edge of this research, Plureon, has developed a line of stem cells from medical discarded placental tissue, thus resolving potential moral issues associated with stem cell research.  Plureon is in the research stage, and their new line of cells has been effective in curing certain diseases in small animals.  Their goal is to develop therapies for humans, and they are seeking FDA approval.